Emollient Market - Global Forecast to 2030
商品番号 : SMB-80914
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年6月 |
| ページ数 | 276 |
| 図表数 | 401 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
本レポートは、エモリエント市場をタイプ、形状、用途、地域に基づいてセグメント化し、様々な地域における市場全体の推定価値（百万米ドル）を示しています。主要業界プレーヤーの詳細な分析を実施し、エモリエント市場に関連する各社の事業概要、サービス、主要戦略に関する洞察を提供しています。
The global emollient market size is projected to reach USD 4.08 billion by 2030 from USD 3.03 billion in 2024, at a CAGR of 5.15%. The increasing popularity of moisturizers, lotions, and anti-aging skin care products is a primary factor boosting the demand for emollients and propelling the market growth. Emollients are vital in keeping skin hydrated, soft, smooth, and healthy-looking by replenishing the skin’s barrier. As consumers continue to look for products that will give them soft, radiant, and youthful-looking skin, especially in more developed regions like Europe and North America, cosmetic formulators are turning to innovative emollients to help deliver on these changing demands. This development, driven by trends toward skin wellness, clean beauty, and dermatologically tested products, increases the popularity of emollients in today’s formulations, making them essential in everyday skin care regimens.
世界のエモリエント市場規模は、2024年の30億3,000万米ドルから2030年には40億8,000万米ドルに達し、年平均成長率（CAGR）5.15%で成長すると予測されています。保湿剤、ローション、アンチエイジングスキンケア製品の人気の高まりが、エモリエント需要を押し上げ、市場の成長を牽引する主な要因です。エモリエントは、肌のバリア機能を補うことで、肌に潤いを与え、柔らかく、滑らかで、健康的な印象を保つために不可欠です。特に欧州や北米などの先進地域では、消費者が柔らかく、輝く、若々しい肌をもたらす製品を求めており、化粧品メーカーは、変化する需要に応えるため、革新的なエモリエントに注目しています。肌の健康、クリーンビューティー、皮膚科医によるテスト済みの製品へのトレンドに後押しされたこの展開により、今日の処方におけるエモリエントの人気が高まり、毎日のスキンケアに欠かせないものとなっています。
“Fatty alcohols segment accounted for the second-largest share of the emollient market in 2024.”
The fatty alcohols segment held the second-largest share of the global emollient market, in terms of value, in 2024. Fatty alcohols, such as cetyl and stearyl alcohols, are becoming more widely employed for their occlusive properties. By retaining moisture and reducing transepidermal water loss (TEWL), skin hydration levels are increased, and skin resilience is improved, which is ideal for dry and sensitive skin formulations. As consumers increasingly seek solutions to support skin barrier health, the demand for products featuring barrier-strengthening ingredients has skyrocketed. Fatty alcohols not only provide visible softness and moisture, but they also support long-term skin conditioning. Their utility in dermatologically approved formulations, particularly within eczema-prone or aging skin creams and balms, keeps the momentum of their novel adoption rolling into the ever-booming skin care applications.
“Liquid form is projected to be the fastest-growing segment in the global emollient market during the forecast period.”
Liquid form is projected to be the fastest-growing segment in the global emollient market between 2025 and 2030. Liquid emollients are essential hair care formulations, especially for conditioners, serums, and scalp treatments. They help smooth down hair cuticles to combat frizz and add lubrication for easier combability and shine. Further, they gently moisturize the scalp without leaving pores clogged. This is an increasingly important benefit sought after by consumers in pursuit of healthier hair growth. As demand increases for multi-use hair oils and leave-ins, lighter, more fluid emollients are being incorporated for their nutrient and softening benefits without heaviness, particularly in naturally derived and silicone-free products.
“Deodorants was the third-largest application segment of the emollient market, in terms of value, in 2024.”
The deodorants segment was the third-largest application in the global emollient market, in terms of value, in 2024. Rising consumer preference for alcohol-free deodorants because of their skin-drying and stinging properties is escalating the need for alcohol-free products formulated with emollients. These deodorants enriched with emollients ensure a smooth application while delivering a soft, moisturized feel. Brands launching clean, vegan, or natural deodorants can use plant-based emollients such as shea butter, cocoa butter, or jojoba oil to improve glide and skin feel. With consumers increasingly focused on ingredient transparency and the health of their skin in the long term, emollients are playing a key role in creating effective deodorants, particularly within premium and environmentally friendly product ranges.
“Asia Pacific was the second-largest region in the emollient market, in terms of value, in 2024.”
Asia Pacific was the second-largest region in the emollient market in 2024. The growing middle-class population in markets such as China, India, Indonesia, and Vietnam is driving the demand for more affordable and effective personal care products with skin-nourishing actives. With an increase in disposable incomes, consumers are moving rapidly from basics to skincare and hair care products with high-quality emollient products such as esters, fatty alcohols, and natural oils. Growing urbanization and a higher general beauty awareness are additionally urging native manufacturers to innovate and introduce new emollient-rich lotions, serums, and creams designed to meet consumer demands.
- By Company Type: Tier 1 – 55%, Tier 2 – 25%, and Tier 3 – 20%
- By Designation: Directors – 50%, Managers – 30%, and Others – 20%
- By Region: North America – 40%, Europe – 35%, Asia Pacific – 20%, and the Rest of the World – 5%
The key players profiled in the report include BASF SE (Germany), Croda International plc (UK), Evonik Industries AG (Germany), Lubrizol Corporation (US), Clariant AG (Switzerland), Eastman Chemical Company (US), Ashland Inc. (US), Innospec Inc. (US), Lonza Group (Switzerland), and Stepan Company (US).
Research Coverage
This report segments the emollient market based on type, form, application, and region and provides estimations of value (USD million) for the overall market size across various regions. A detailed analysis of key industry players has been conducted to provide insights into their business overviews, services, and key strategies associated with the emollient market.
Reasons to Buy this Report
This research report is focused on various levels of analysis—industry analysis (industry trends), market share analysis of top players, and company profiles, which together provide an overall view of the competitive landscape, emerging and high-growth segments of the emollient market, high-growth regions, and market drivers, restraints, and opportunities.
The report provides insights into the following points:
- Market Penetration: Comprehensive information on emollients offered by top players in the global market
- Analysis of key drivers (growing consumer focus on skincare, increasing demand for natural and sustainable ingredients, and expansion of premium personal care segments), restraints (raw material price volatility and regulatory complexities and compliance costs), opportunities (expansion in emerging markets and advanced functional benefits), and challenges (balancing performance and sustainability as well as formulation complexity and compatibility issues) influencing the growth of the emollient market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the emollient market.
- Market Development: Comprehensive information about lucrative emerging markets — the report analyzes the markets for emollients across regions.
- Market Diversification: Exhaustive information about new products, untapped regions, and recent developments in the global emollient market
- Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the emollient market.
Table of Contents
1 INTRODUCTION 25
1.1 STUDY OBJECTIVES 25
1.2 MARKET DEFINITION 25
1.3 STUDY SCOPE 26
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 26
1.3.2 INCLUSIONS AND EXCLUSIONS OF STUDY 27
1.3.3 YEARS CONSIDERED 30
1.3.4 CURRENCY CONSIDERED 31
1.3.5 UNIT CONSIDERED 31
1.4 STAKEHOLDERS 31
2 RESEARCH METHODOLOGY 32
2.1 RESEARCH DATA 32
2.1.1 SECONDARY DATA 32
2.1.1.1 Key data from secondary sources 33
2.1.2 PRIMARY DATA 33
2.1.2.1 Key primary participants 33
2.1.2.2 Key industry insights 34
2.1.2.3 Breakdown of primary interviews 34
2.2 MARKET SIZE ESTIMATION 35
2.2.1 BOTTOM-UP APPROACH 35
2.2.2 TOP-DOWN APPROACH 37
2.3 DATA TRIANGULATION 38
2.4 GROWTH FORECAST 39
2.4.1 SUPPLY-SIDE ANALYSIS 40
2.4.2 DEMAND-SIDE ANALYSIS 40
2.5 RESEARCH ASSUMPTIONS 41
2.6 RESEARCH LIMITATIONS 42
2.7 RISK ASSESSMENT 42
3 EXECUTIVE SUMMARY 43
4 PREMIUM INSIGHTS 46
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN EMOLLIENTS MARKET 46
4.2 EMOLLIENTS MARKET, BY REGION 46
4.3 EUROPE: EMOLLIENTS MARKET, BY APPLICATION AND COUNTRY 47
4.4 REGIONAL ANALYSIS: EMOLLIENTS MARKET, BY TYPE 47
4.5 EMOLLIENTS MARKET, BY COUNTRY 48
5 MARKET OVERVIEW 49
5.1 INTRODUCTION 49
5.2 MARKET DYNAMICS 50
5.2.1 DRIVERS 50
5.2.1.1 Growing consumer focus on skin care 50
5.2.1.2 Increasing demand for natural and sustainable ingredients 51
5.2.1.3 Expansion of premium personal care segments 51
5.2.2 RESTRAINTS 51
5.2.2.1 Raw material price volatility 51
5.2.2.2 Regulatory complexities and compliance costs 52
5.2.3 OPPORTUNITIES 52
5.2.3.1 Expansion in emerging markets 52
5.2.3.2 Advanced functional benefits 53
5.2.4 CHALLENGES 53
5.2.4.1 Balancing performance and sustainability 53
5.2.4.2 Formulatory complexity and compatibility issues 53
5.3 PORTER’S FIVE FORCES ANALYSIS 54
5.3.1 THREAT OF NEW ENTRANTS 55
5.3.2 THREAT OF SUBSTITUTES 55
5.3.3 BARGAINING POWER OF SUPPLIERS 55
5.3.4 BARGAINING POWER OF BUYERS 55
5.3.5 INTENSITY OF COMPETITIVE RIVALRY 56
5.4 KEY STAKEHOLDERS AND BUYING CRITERIA 56
5.4.1 KEY STAKEHOLDERS IN BUYING PROCESS 56
5.4.2 BUYING CRITERIA 57
5.5 MACROECONOMIC OUTLOOK 58
5.5.1 GDP TRENDS AND FORECAST 58
6 INDUSTRY TRENDS 59
6.1 SUPPLY CHAIN ANALYSIS 59
6.1.1 RAW MATERIAL SUPPLIERS 60
6.1.2 MANUFACTURERS 60
6.1.3 DISTRIBUTION NETWORKS 60
6.1.4 END USERS 60
6.2 PRICING ANALYSIS 61
6.2.1 AVERAGE SELLING PRICE OF EMOLLIENTS OFFERED BY KEY PLAYERS 61
6.2.2 AVERAGE SELLING PRICE TREND OF EMOLLIENTS, BY REGION 62
6.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 63
6.4 ECOSYSTEM ANALYSIS 64
6.5 CASE STUDY ANALYSIS 65
6.5.1 REVOLUTIONIZING CLEAN BEAUTY WITH PLANTASENS PRO LM 65
6.5.2 ELEVATING SKINCARE AESTHETICS THROUGH FORMULATION SCIENCE 66
6.6 TECHNOLOGY ANALYSIS 66
6.6.1 KEY TECHNOLOGIES 66
6.6.1.1 Esterification and hydrogenation technologies 66
6.6.1.2 Encapsulation and delivery systems 67
6.6.2 COMPLIMENTARY TECHNOLOGIES 67
6.6.2.1 Green chemistry and bio-based synthesis 67
6.7 TRADE ANALYSIS 67
6.7.1 IMPORT SCENARIO (HS CODE 3304) 68
6.7.2 EXPORT SCENARIO (HS CODE 3304) 69
6.8 REGULATORY LANDSCAPE 70
6.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70
6.8.2 REGULATORY FRAMEWORK 73
6.8.2.1 ISO 16128 – Guidelines for Natural and Organic Cosmetic Ingredients 73
6.8.2.2 Regulation (EC) No 1223/2009 – EU Cosmetic Products Regulation 74
6.9 KEY CONFERENCES AND EVENTS 74
6.10 INVESTMENT AND FUNDING SCENARIO 75
6.11 PATENT ANALYSIS 75
6.11.1 APPROACH 75
6.11.2 DOCUMENT TYPES 75
6.11.3 TOP APPLICANTS 78
6.11.4 JURISDICTION ANALYSIS 80
6.12 IMPACT OF 2025 US TARIFF – OVERVIEW 80
6.12.1 INTRODUCTION 80
6.12.2 KEY TARIFF RATES 81
6.12.3 PRICE IMPACT ANALYSIS 81
6.12.4 IMPACT ON COUNTRY/REGION 82
6.12.4.1 US 82
6.12.4.2 Europe 82
6.12.4.3 Asia Pacific 83
6.12.5 IMPACT ON APPLICATIONS 84
6.13 IMPACT OF AI/GEN AI ON EMOLLIENTS MARKET 85
7 EMOLLIENTS MARKET, BY TYPE 87
7.1 INTRODUCTION 88
7.2 ESTERS 90
7.2.1 OPTIMIZING ACTIVE DELIVERY WITH ESTERS TO DRIVE MARKET EXPANSION 90
7.3 FATTY ALCOHOLS 91
7.3.1 MULTIFUNCTIONALITY PROPERTY OF FATTY ALCOHOLS TO FUEL MARKET GROWTH 91
7.4 FATTY ACIDS 93
7.4.1 RISING PREFERENCE FOR NATURAL LIPIDS TO DRIVE MARKET GROWTH 93
7.5 ETHERS 95
7.5.1 ENHANCED SKIN DELIVERY CAPABILITIES TO FUEL MARKET EXPANSION 95
7.6 SILICONES 96
7.6.1 ENHANCED WATER RESISTANCE CAPABILITIES TO PROPEL MARKET 96
7.7 OTHER TYPES 98
8 EMOLLIENTS MARKET, BY PRODUCT TYPE 100
8.1 INTRODUCTION 100
8.2 CREAMS 100
8.3 LOTIONS 100
8.4 OINTMENTS 100
8.5 OILS 101
8.6 BUTTERS 101
8.7 BALMS & STICKS 101
8.8 GELS 101
8.9 SPRAYS & MISTS 102
9 EMOLLIENTS MARKET, BY SOURCE 103
9.1 INTRODUCTION 103
9.2 NATURAL 103
9.2.1 PLANT-DERIVED 103
9.2.2 ANIMAL-DERIVED 103
9.3 SYNTHETIC 104
9.3.1 PETROLEUM-BASED 104
9.3.2 LAB-SYNTHESIZED ESTERS 104
10 EMOLLIENTS MARKET, BY FORM 105
10.1 INTRODUCTION 106
10.2 LIQUID 107
10.2.1 ENHANCED SENSORY EXPERIENCE TO FUEL DEMAND 107
10.3 SOLID 109
10.3.1 STRUCTURE-BUILDING FUNCTIONALITY TO DRIVE MARKET DEMAND 109
11 EMOLLIENTS MARKET, BY FUNCTION 111
11.1 INTRODUCTION 111
11.2 SKIN CONDITIONING 111
11.3 BARRIER ENHANCEMENT 111
11.4 LUBRICATION 111
11.5 TEXTURE IMPROVEMENT 112
11.6 MOISTURIZATION 112
12 EMOLLIENTS MARKET, BY APPLICATION 113
12.1 INTRODUCTION 114
12.2 SKIN CARE 116
12.2.1 RISING DEMAND FOR MULTIFUNCTIONAL FORMULATIONS TO DRIVE MARKET GROWTH 116
12.3 HAIR CARE 117
12.3.1 ADVANCED HAIR REPAIR SOLUTIONS TO FUEL GROWTH OF SPECIALTY EMOLLIENTS 117
12.4 DEODORANTS 119
12.4.1 RISE IN CLEAN-LABEL DEODORANTS TO DRIVE MARKET GROWTH 119
12.5 ORAL CARE 121
12.5.1 INCREASING DEMAND FOR CLEAN-LABEL ORAL PRODUCTS TO BOOST MARKET DEMAND 121
12.6 OTHER APPLICATIONS 122
13 EMOLLIENTS MARKET, BY REGION 125
13.1 INTRODUCTION 126
13.2 ASIA PACIFIC 128
13.2.1 CHINA 134
13.2.1.1 Rise in domestic beauty brands with ingredient innovation to drive market 134
13.2.2 JAPAN 135
13.2.2.1 Sensory innovation in formulations to fuel growth 135
13.2.3 INDIA 137
13.2.3.1 Increasing penetration of affordable and personalized skin care products to drive market 137
13.2.4 SOUTH KOREA 139
13.2.4.1 Demand for glass skin aesthetics to boost market growth 139
13.3 NORTH AMERICA 140
13.3.1 US 146
13.3.1.1 Skin wellness trends to drive market growth 146
13.3.2 CANADA 148
13.3.2.1 Climate-resilient skincare needs to drive market 148
13.3.3 MEXICO 150
13.3.3.1 Expanding urbanization to support market growth 150
13.4 EUROPE 151
13.4.1 GERMANY 157
13.4.1.1 Strong industrial base to boost market 157
13.4.2 ITALY 159
13.4.2.1 Natural beauty traditions to drive ingredient usage 159
13.4.3 FRANCE 161
13.4.3.1 Strong heritage in luxury skincare to drive market 161
13.4.4 UK 162
13.4.4.1 Stringent regulatory framework to propel market 162
13.4.5 SPAIN 164
13.4.5.1 Climate-adaptive skincare routines to drive demand 164
13.4.6 POLAND 166
13.4.6.1 Demand for modern, well-formulated skincare to drive market 166
13.5 MIDDLE EAST & AFRICA 167
13.5.1 GCC COUNTRIES 173
13.5.1.1 Saudi Arabia 173
13.5.1.1.1 Rising demand for luxury beauty to drive market 173
13.5.2 TURKEY 175
13.5.2.1 Heritage beauty practices to drive market shift 175
13.5.3 IRAN 176
13.5.3.1 Rising demand for skin care to drive market 176
13.5.4 SOUTH AFRICA 178
13.5.4.1 Need for hydrating products to boost market growth 178
13.6 SOUTH AMERICA 180
13.6.1 BRAZIL 185
13.6.1.1 Rapidly expanding economy to boost market 185
14 COMPETITIVE LANDSCAPE 187
14.1 INTRODUCTION 187
14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 187
14.3 MARKET SHARE ANALYSIS 188
14.4 REVENUE ANALYSIS OF TOP FIVE PLAYERS 191
14.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 192
14.5.1 STARS 192
14.5.2 EMERGING LEADERS 192
14.5.3 PERVASIVE PLAYERS 192
14.5.4 PARTICIPANTS 192
14.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 194
14.5.5.1 Company footprint 194
14.5.5.2 Region footprint 195
14.5.5.3 Form footprint 196
14.5.5.4 Type footprint 197
14.5.5.5 Application footprint 198
14.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 199
14.6.1 PROGRESSIVE COMPANIES 199
14.6.2 RESPONSIVE COMPANIES 199
14.6.3 DYNAMIC COMPANIES 199
14.6.4 STARTING BLOCKS 199
14.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 200
14.6.5.1 Detailed list of key startups/SMES 200
14.6.5.2 Competitive benchmarking of key startups/SMEs 201
14.7 BRAND/PRODUCT COMPARISON ANALYSIS 202
14.8 COMPANY VALUATION AND FINANCIAL METRICS 203
14.9 COMPETITIVE SCENARIO 204
14.9.1 PRODUCT LAUNCHES 204
14.9.2 DEALS 206
14.9.3 EXPANSIONS 208
14.9.4 OTHER DEVELOPMENTS 209
15 COMPANY PROFILES 211
15.1 KEY PLAYERS 211
15.1.1 BASF SE 211
15.1.1.1 Business overview 211
15.1.1.2 Products offered 212
15.1.1.3 Recent developments 213
15.1.1.3.1 Product launches 213
15.1.1.3.2 Deals 214
15.1.1.3.3 Expansions 214
15.1.1.3.4 Other developments 214
15.1.1.4 MnM view 215
15.1.1.4.1 Key strengths 215
15.1.1.4.2 Strategic choices 215
15.1.1.4.3 Weaknesses & competitive threats 215
15.1.2 CRODA INTERNATIONAL PLC 216
15.1.2.1 Business overview 216
15.1.2.2 Products offered 217
15.1.2.3 Recent developments 218
15.1.2.3.1 Product launches 218
15.1.2.3.2 Deals 218
15.1.2.3.3 Expansions 219
15.1.2.3.4 Other developments 219
15.1.2.4 MnM view 220
15.1.2.4.1 Key strengths 220
15.1.2.4.2 Strategic choices 220
15.1.2.4.3 Weaknesses & competitive threats 220
15.1.3 EVONIK INDUSTRIES AG 221
15.1.3.1 Business overview 221
15.1.3.2 Products offered 222
15.1.3.3 Recent developments 223
15.1.3.3.1 Product launches 223
15.1.3.3.2 Deals 224
15.1.3.3.3 Expansions 224
15.1.3.3.4 Other developments 224
15.1.3.4 MnM view 225
15.1.3.4.1 Key strengths 225
15.1.3.4.2 Strategic choices 225
15.1.3.4.3 Weaknesses & competitive threats 225
15.1.4 CLARIANT AG 226
15.1.4.1 Business overview 226
15.1.4.2 Products offered 227
15.1.4.3 Recent developments 228
15.1.4.3.1 Product launches 228
15.1.4.3.2 Deals 229
15.1.4.3.3 Expansions 229
15.1.4.3.4 Other developments 229
15.1.4.4 MnM view 230
15.1.4.4.1 Key strengths 230
15.1.4.4.2 Strategic choices 230
15.1.4.4.3 Weaknesses & competitive threats 230
15.1.5 THE LUBRIZOL CORPORATION 231
15.1.5.1 Business overview 231
15.1.5.2 Products offered 231
15.1.5.3 Recent developments 232
15.1.5.3.1 Product launches 232
15.1.5.3.2 Deals 232
15.1.5.3.3 Expansions 233
15.1.5.3.4 Other developments 233
15.1.5.4 MnM view 233
15.1.5.4.1 Key strengths 233
15.1.5.4.2 Strategic choices 234
15.1.5.4.3 Weaknesses & competitive threats 234
15.1.6 EASTMAN CHEMICAL COMPANY 235
15.1.6.1 Business overview 235
15.1.6.2 Products offered 236
15.1.6.3 Recent developments 237
15.1.6.3.1 Product launches 237
15.1.6.3.2 Deals 237
15.1.6.3.3 Expansions 238
15.1.6.3.4 Other developments 238
15.1.7 ASHLAND INC. 239
15.1.7.1 Business overview 239
15.1.7.2 Products offered 240
15.1.7.3 Recent developments 241
15.1.7.3.1 Product launches 241
15.1.7.3.2 Deals 242
15.1.7.3.3 Expansions 242
15.1.8 INNOSPEC INC. 243
15.1.8.1 Business overview 243
15.1.8.2 Products offered 244
15.1.8.3 Recent developments 245
15.1.8.3.1 Product launches 245
15.1.8.3.2 Expansions 245
15.1.9 LONZA GROUP LTD. 246
15.1.9.1 Business overview 246
15.1.9.2 Products offered 247
15.1.10 STEPAN COMPANY 249
15.1.10.1 Business overview 249
15.1.10.2 Products offered 250
15.2 STARTUPS/SMES 252
15.2.1 KLK OLEO 252
15.2.2 SYENSQO SA/NV 253
15.2.3 GATTEFOSSÉ 253
15.2.4 SASOL LIMITED 254
15.2.5 DOW INC. 254
15.2.6 COVESTRO AG 255
15.2.7 VANTAGE SPECIALTY CHEMICALS 255
15.2.8 BERG+SCHMIDT GMBH & CO. KG 256
15.2.9 IOI OLEO GMBH 256
15.2.10 CARGILL, INC. 257
15.2.11 NOURYON 257
15.2.12 NIKKO CHEMICALS CO., LTD. 258
15.2.13 HALLSTAR 258
15.2.14 COLONIAL CHEMICAL, INC. 259
15.2.15 ELEMENTIS PLC 259
16 ADJACENT & RELATED MARKETS 260
16.1 INTRODUCTION 260
16.2 LIMITATION 260
16.3 PERSONAL CARE INGREDIENTS MARKET 260
16.3.1 MARKET DEFINITION 260
16.3.2 MARKET OVERVIEW 261
16.4 PERSONAL CARE INGREDIENTS MARKET, BY REGION 261
16.4.1 EUROPE 261
16.4.2 NORTH AMERICA 263
16.4.3 ASIA PACIFIC 264
16.4.4 MIDDLE EAST & AFRICA 265
16.4.5 SOUTH AMERICA 266
17 APPENDIX 268
17.1 DISCUSSION GUIDE 268
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 272
17.3 CUSTOMIZATION OPTIONS 274
17.4 RELATED REPORTS 274
17.5 AUTHOR DETAILS 275
LIST OF TABLES
TABLE 1 EMOLLIENTS MARKET: DEFINITION AND INCLUSIONS, BY TYPE 27
TABLE 2 EMOLLIENTS MARKET: DEFINITION AND INCLUSIONS, BY PRODUCT TYPE 28
TABLE 3 EMOLLIENTS MARKET: DEFINITION AND INCLUSIONS, BY SOURCE 29
TABLE 4 EMOLLIENTS MARKET: DEFINITION AND INCLUSIONS, BY FORM 29
TABLE 5 EMOLLIENTS MARKET: DEFINITION AND INCLUSIONS, BY FUNCTION 29
TABLE 6 EMOLLIENTS MARKET: DEFINITION AND INCLUSIONS, BY APPLICATION 30
TABLE 7 EMOLLIENTS MARKET: PORTER’S FIVE FORCES ANALYSIS 56
TABLE 8 IMPACT OF STAKEHOLDERS ON BUYING PROCESS OF TOP
THREE APPLICATIONS (%) 57
TABLE 9 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 57
TABLE 10 GDP TRENDS AND FORECAST OF MAJOR ECONOMIES, 2021–2030 (USD BILLION) 58
TABLE 11 AVERAGE SELLING PRICE OF EMOLLIENTS OFFERED BY KEY PLAYERS,
BY APPLICATION, 2024 (USD/KG) 61
TABLE 12 AVERAGE SELLING PRICE TREND OF EMOLLIENTS, BY REGION,
2022–2030 (USD/KG) 62
TABLE 13 ROLE OF COMPANIES IN EMOLLIENTS ECOSYSTEM 64
TABLE 14 IMPORT DATA RELATED TO EMOLLIENTS, BY REGION, 2019–2024 (USD MILLION) 68
TABLE 15 EXPORT DATA RELATED TO EMOLLIENTS, BY REGION, 2019–2024 (USD MILLION) 69
TABLE 16 GLOBAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70
TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71
TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72
TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72
TABLE 20 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
TABLE 21 SOUTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
TABLE 22 EMOLLIENTS MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2025–2026 74
TABLE 23 EMOLLIENTS MARKET: FUNDING/INVESTMENT SCENARIO, 2023–2025 75
TABLE 24 PATENT STATUS, 2014–2024 76
TABLE 25 LIST OF MAJOR PATENTS RELATED TO EMOLLIENTS, 2014–2024 78
TABLE 26 PATENTS BY COLGATE-PALMOLIVE COMPANY 79
TABLE 27 US ADJUSTED RECIPROCAL TARIFF RATES 81
TABLE 28 EMOLLIENTS MARKET, BY TYPE, 2020–2024 (USD MILLION) 88
TABLE 29 EMOLLIENTS MARKET, BY TYPE, 2025–2030 (USD MILLION) 89
TABLE 30 EMOLLIENTS MARKET, BY TYPE, 2020–2024 (KILOTON) 89
TABLE 31 EMOLLIENTS MARKET, BY TYPE, 2025–2030 (KILOTON) 89
TABLE 32 ESTERS: EMOLLIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 90
TABLE 33 ESTERS: EMOLLIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 90
TABLE 34 ESTERS: EMOLLIENTS MARKET, BY REGION, 2020–2024 (KILOTON) 91
TABLE 35 ESTERS: EMOLLIENTS MARKET, BY REGION, 2025–2030 (KILOTON) 91
TABLE 36 FATTY ALCOHOLS: EMOLLIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 92
TABLE 37 FATTY ALCOHOLS: EMOLLIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 92
TABLE 38 FATTY ALCOHOLS: EMOLLIENTS MARKET, BY REGION, 2020–2024 (KILOTON) 92
TABLE 39 FATTY ALCOHOLS: EMOLLIENTS MARKET, BY REGION, 2025–2030 (KILOTON) 93
TABLE 40 FATTY ACIDS: EMOLLIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 93
TABLE 41 FATTY ACIDS: EMOLLIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 94
TABLE 42 FATTY ACIDS: EMOLLIENTS MARKET, BY REGION, 2020–2024 (KILOTON) 94
TABLE 43 FATTY ACIDS: EMOLLIENTS MARKET, BY REGION, 2025–2030 (KILOTON) 94
TABLE 44 ETHERS: EMOLLIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 95
TABLE 45 ETHERS: EMOLLIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 95
TABLE 46 ETHERS: EMOLLIENTS MARKET, BY REGION, 2020–2024 (KILOTON) 96
TABLE 47 ETHERS: EMOLLIENTS MARKET, BY REGION, 2025–2030 (KILOTON) 96
TABLE 48 SILICONES: EMOLLIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 97
TABLE 49 SILICONES: EMOLLIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 97
TABLE 50 SILICONES: EMOLLIENTS MARKET, BY REGION, 2020–2024 (KILOTON) 97
TABLE 51 SILICONES: EMOLLIENTS MARKET, BY REGION, 2025–2030 (KILOTON) 98
TABLE 52 OTHER TYPES: EMOLLIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 98
TABLE 53 OTHER TYPES: EMOLLIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 98
TABLE 54 OTHER TYPES: EMOLLIENTS MARKET, BY REGION, 2020–2024 (KILOTON) 99
TABLE 55 OTHER TYPES: EMOLLIENTS MARKET, BY REGION, 2025–2030 (KILOTON) 99
TABLE 56 EMOLLIENTS MARKET, BY FORM, 2020–2024 (USD MILLION) 106
TABLE 57 EMOLLIENTS MARKET, BY FORM, 2025–2030 (USD MILLION) 106
TABLE 58 EMOLLIENTS MARKET, BY FORM, 2020–2024 (KILOTON) 107
TABLE 59 EMOLLIENTS MARKET, BY FORM, 2025–2030 (KILOTON) 107
TABLE 60 LIQUID FORM: EMOLLIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 108
TABLE 61 LIQUID FORM: EMOLLIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 108
TABLE 62 LIQUID FORM: EMOLLIENTS MARKET, BY REGION, 2020–2024 (KILOTON) 108
TABLE 63 LIQUID FORM: EMOLLIENTS MARKET, BY REGION, 2025–2030 (KILOTON) 109
TABLE 64 SOLID FORM: EMOLLIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 109
TABLE 65 SOLID FORM: EMOLLIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 110
TABLE 66 SOLID FORM: EMOLLIENTS MARKET, BY REGION, 2020–2024 (KILOTON) 110
TABLE 67 SOLID FORM: EMOLLIENTS MARKET, BY REGION, 2025–2030 (KILOTON) 110
TABLE 68 EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 114
TABLE 69 EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 115
TABLE 70 EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 115
TABLE 71 EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 115
TABLE 72 SKIN CARE: EMOLLIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 116
TABLE 73 SKIN CARE: EMOLLIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 116
TABLE 74 SKIN CARE: EMOLLIENTS MARKET, BY REGION, 2020–2024 (KILOTON) 117
TABLE 75 SKIN CARE: EMOLLIENTS MARKET, BY REGION, 2025–2030 (KILOTON) 117
TABLE 76 HAIR CARE: EMOLLIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 118
TABLE 77 HAIR CARE: EMOLLIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 118
TABLE 78 HAIR CARE: EMOLLIENTS MARKET, BY REGION, 2020–2024 (KILOTON) 118
TABLE 79 HAIR CARE: EMOLLIENTS MARKET, BY REGION, 2025–2030 (KILOTON) 119
TABLE 80 DEODORANTS: EMOLLIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 119
TABLE 81 DEODORANTS: EMOLLIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 120
TABLE 82 DEODORANTS: EMOLLIENTS MARKET, BY REGION, 2020–2024 (KILOTON) 120
TABLE 83 DEODORANTS: EMOLLIENTS MARKET, BY REGION, 2025–2030 (KILOTON) 120
TABLE 84 ORAL CARE: EMOLLIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 121
TABLE 85 ORAL CARE: EMOLLIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 121
TABLE 86 ORAL CARE: EMOLLIENTS MARKET, BY REGION, 2020–2024 (KILOTON) 122
TABLE 87 ORAL CARE: EMOLLIENTS MARKET, BY REGION, 2025–2030 (KILOTON) 122
TABLE 88 OTHER APPLICATIONS: EMOLLIENTS MARKET, BY REGION,
2020–2024 (USD MILLION) 123
TABLE 89 OTHER APPLICATIONS: EMOLLIENTS MARKET, BY REGION,
2025–2030 (USD MILLION) 123
TABLE 90 OTHER APPLICATIONS: EMOLLIENTS MARKET, BY REGION, 2020–2024 (KILOTON) 123
TABLE 91 OTHER APPLICATIONS: EMOLLIENTS MARKET, BY REGION, 2025–2030 (KILOTON) 124
TABLE 92 EMOLLIENTS MARKET, BY REGION, 2020–2024 (USD MILLION) 126
TABLE 93 EMOLLIENTS MARKET, BY REGION, 2025–2030 (USD MILLION) 127
TABLE 94 EMOLLIENTS MARKET, BY REGION, 2020–2024 (KILOTON) 127
TABLE 95 EMOLLIENTS MARKET, BY REGION, 2025–2030 (KILOTON) 127
TABLE 96 ASIA PACIFIC: EMOLLIENTS MARKET, BY TYPE, 2020–2024 (USD MILLION) 129
TABLE 97 ASIA PACIFIC: EMOLLIENTS MARKET, BY TYPE, 2025–2030 (USD MILLION) 129
TABLE 98 ASIA PACIFIC: EMOLLIENTS MARKET, BY TYPE, 2020–2024(KILOTON) 129
TABLE 99 ASIA PACIFIC: EMOLLIENTS MARKET, BY TYPE, 2025–2030 (KILOTON) 130
TABLE 100 ASIA PACIFIC: EMOLLIENTS MARKET, BY FORM, 2020–2024 (USD MILLION) 130
TABLE 101 ASIA PACIFIC: EMOLLIENTS MARKET, BY FORM, 2025–2030 (USD MILLION) 130
TABLE 102 ASIA PACIFIC: EMOLLIENTS MARKET, BY FORM, 2020–2024 (KILOTON) 131
TABLE 103 ASIA PACIFIC: EMOLLIENTS MARKET, BY FORM, 2025–2030 (KILOTON) 131
TABLE 104 ASIA PACIFIC: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 131
TABLE 105 ASIA PACIFIC: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 131
TABLE 106 ASIA PACIFIC: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 132
TABLE 107 ASIA PACIFIC: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 132
TABLE 108 ASIA PACIFIC: EMOLLIENTS MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 132
TABLE 109 ASIA PACIFIC: EMOLLIENTS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 133
TABLE 110 ASIA PACIFIC: EMOLLIENTS MARKET, BY COUNTRY, 2020–2024 (KILOTON) 133
TABLE 111 ASIA PACIFIC: EMOLLIENTS MARKET, BY COUNTRY, 2025–2030 (KILOTON) 133
TABLE 112 CHINA: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 134
TABLE 113 CHINA: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 134
TABLE 114 CHINA: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 135
TABLE 115 CHINA: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 135
TABLE 116 JAPAN: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 136
TABLE 117 JAPAN: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 136
TABLE 118 JAPAN: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 136
TABLE 119 JAPAN: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 137
TABLE 120 INDIA: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 137
TABLE 121 INDIA: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 138
TABLE 122 INDIA: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 138
TABLE 123 INDIA: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 138
TABLE 124 SOUTH KOREA: EMOLLIENTS MARKET, BY APPLICATION,
2020–2024 (USD MILLION) 139
TABLE 125 SOUTH KOREA: EMOLLIENTS MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 139
TABLE 126 SOUTH KOREA: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 140
TABLE 127 SOUTH KOREA: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 140
TABLE 128 NORTH AMERICA: EMOLLIENTS MARKET, BY TYPE, 2020–2024 (USD MILLION) 141
TABLE 129 NORTH AMERICA: EMOLLIENTS MARKET, BY TYPE, 2025–2030 (USD MILLION) 142
TABLE 130 NORTH AMERICA: EMOLLIENTS MARKET, BY TYPE, 2020–2024 (KILOTON) 142
TABLE 131 NORTH AMERICA: EMOLLIENTS MARKET, BY TYPE, 2025–2030 (KILOTON) 143
TABLE 132 NORTH AMERICA: EMOLLIENTS MARKET, BY FORM, 2020–2024 (USD MILLION) 143
TABLE 133 NORTH AMERICA: EMOLLIENTS MARKET, BY FORM, 2025–2030 (USD MILLION) 143
TABLE 134 NORTH AMERICA: EMOLLIENTS MARKET, BY FORM, 2020–2024 (KILOTON) 143
TABLE 135 NORTH AMERICA: EMOLLIENTS MARKET, BY FORM, 2025–2030 (KILOTON) 144
TABLE 136 NORTH AMERICA: EMOLLIENTS MARKET, BY APPLICATION,
2020–2024 (USD MILLION) 144
TABLE 137 NORTH AMERICA: EMOLLIENTS MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 144
TABLE 138 NORTH AMERICA: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 145
TABLE 139 NORTH AMERICA: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 145
TABLE 140 NORTH AMERICA: EMOLLIENTS MARKET, BY COUNTRY,
2020–2024 (USD MILLION) 145
TABLE 141 NORTH AMERICA: EMOLLIENTS MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 145
TABLE 142 NORTH AMERICA: EMOLLIENTS MARKET, BY COUNTRY, 2020–2024 (KILOTON) 146
TABLE 143 NORTH AMERICA: EMOLLIENTS MARKET, BY COUNTRY, 2025–2030 (KILOTON) 146
TABLE 144 US: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 147
TABLE 145 US: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 147
TABLE 146 US: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 147
TABLE 147 US: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 148
TABLE 148 CANADA: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024(USD MILLION) 148
TABLE 149 CANADA: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 149
TABLE 150 CANADA: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 149
TABLE 151 CANADA: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 149
TABLE 152 MEXICO: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 150
TABLE 153 MEXICO: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 150
TABLE 154 MEXICO: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 151
TABLE 155 MEXICO: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 151
TABLE 156 EUROPE: EMOLLIENTS MARKET, BY TYPE, 2020–2024 (USD MILLION) 152
TABLE 157 EUROPE: EMOLLIENTS MARKET, BY TYPE, 2025–2030 (USD MILLION) 153
TABLE 158 EUROPE: EMOLLIENTS MARKET, BY TYPE, 2020–2024 (KILOTON) 153
TABLE 159 EUROPE: EMOLLIENTS MARKET, BY TYPE, 2025–2030 (KILOTON) 153
TABLE 160 EUROPE: EMOLLIENTS MARKET, BY FORM, 2020–2024 (USD MILLION) 154
TABLE 161 EUROPE: EMOLLIENTS MARKET, BY FORM, 2025–2030 (USD MILLION) 154
TABLE 162 EUROPE: EMOLLIENTS MARKET, BY FORM, 2020–2024 (KILOTON) 154
TABLE 163 EUROPE: EMOLLIENTS MARKET, BY FORM, 2025–2030 (KILOTON) 154
TABLE 164 EUROPE: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 155
TABLE 165 EUROPE: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 155
TABLE 166 EUROPE: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 155
TABLE 167 EUROPE: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 156
TABLE 168 EUROPE: EMOLLIENTS MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 156
TABLE 169 EUROPE: EMOLLIENTS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 156
TABLE 170 EUROPE: EMOLLIENTS MARKET, BY COUNTRY, 2020–2024 (KILOTON) 157
TABLE 171 EUROPE: EMOLLIENTS MARKET, BY COUNTRY, 2025–2030 (KILOTON) 157
TABLE 172 GERMANY: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 158
TABLE 173 GERMANY: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 158
TABLE 174 GERMANY: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 158
TABLE 175 GERMANY: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 159
TABLE 176 ITALY: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 159
TABLE 177 ITALY: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 160
TABLE 178 ITALY: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 160
TABLE 179 ITALY: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 160
TABLE 180 FRANCE: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 161
TABLE 181 FRANCE: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 161
TABLE 182 FRANCE: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 162
TABLE 183 FRANCE: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 162
TABLE 184 UK: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 163
TABLE 185 UK: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 163
TABLE 186 UK: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 163
TABLE 187 UK: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 164
TABLE 188 SPAIN: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 164
TABLE 189 SPAIN: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 165
TABLE 190 SPAIN: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 165
TABLE 191 SPAIN: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 165
TABLE 192 POLAND: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 166
TABLE 193 POLAND: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 166
TABLE 194 POLAND: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 167
TABLE 195 POLAND: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 167
TABLE 196 MIDDLE EAST & AFRICA: EMOLLIENTS MARKET, BY TYPE,
2020–2024 (USD MILLION) 168
TABLE 197 MIDDLE EAST & AFRICA: EMOLLIENTS MARKET, BY TYPE,
2025–2030 (USD MILLION) 168
TABLE 198 MIDDLE EAST & AFRICA: EMOLLIENTS MARKET, BY TYPE, 2020–2024 (KILOTON) 168
TABLE 199 MIDDLE EAST & AFRICA: EMOLLIENTS MARKET, BY TYPE, 2025–2030 (KILOTON) 169
TABLE 200 MIDDLE EAST & AFRICA: EMOLLIENTS MARKET, BY FORM,
2020–2024 (USD MILLION) 169
TABLE 201 MIDDLE EAST & AFRICA: EMOLLIENTS MARKET, BY FORM,
2025–2030 (USD MILLION) 169
TABLE 202 MIDDLE EAST & AFRICA: EMOLLIENTS MARKET, BY FORM, 2020–2024 (KILOTON) 170
TABLE 203 MIDDLE EAST & AFRICA: EMOLLIENTS MARKET, BY FORM, 2025–2030 (KILOTON) 170
TABLE 204 MIDDLE EAST & AFRICA: EMOLLIENTS MARKET, BY APPLICATION,
2020–2024 (USD MILLION) 170
TABLE 205 MIDDLE EAST & AFRICA: EMOLLIENTS MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 170
TABLE 206 MIDDLE EAST & AFRICA: EMOLLIENTS MARKET, BY APPLICATION,
2020–2024 (KILOTON) 171
TABLE 207 MIDDLE EAST & AFRICA: EMOLLIENTS MARKET, BY APPLICATION,
2025–2030 (KILOTON) 171
TABLE 208 MIDDLE EAST & AFRICA: EMOLLIENTS MARKET, BY COUNTRY,
2020–2024 (USD MILLION) 171
TABLE 209 MIDDLE EAST & AFRICA: EMOLLIENTS MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 172
TABLE 210 MIDDLE EAST & AFRICA: EMOLLIENTS MARKET, BY COUNTRY,
2020–2024 (KILOTON) 172
TABLE 211 MIDDLE EAST & AFRICA: EMOLLIENTS MARKET, BY COUNTRY,
2025–2030 (KILOTON) 172
TABLE 212 SAUDI ARABIA: EMOLLIENTS MARKET, BY APPLICATION,
2020–2024 (USD MILLION) 173
TABLE 213 SAUDI ARABIA: EMOLLIENTS MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 174
TABLE 214 SAUDI ARABIA: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 174
TABLE 215 SAUDI ARABIA: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 174
TABLE 216 TURKEY: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 175
TABLE 217 TURKEY: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 175
TABLE 218 TURKEY: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 176
TABLE 219 TURKEY: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 176
TABLE 220 IRAN: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 177
TABLE 221 IRAN: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 177
TABLE 222 IRAN: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 177
TABLE 223 IRAN: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 178
TABLE 224 SOUTH AFRICA: EMOLLIENTS MARKET, BY APPLICATION,
2020–2024 (USD MILLION) 178
TABLE 225 SOUTH AFRICA: EMOLLIENTS MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 179
TABLE 226 SOUTH AFRICA: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 179
TABLE 227 SOUTH AFRICA: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 179
TABLE 228 SOUTH AMERICA: EMOLLIENTS MARKET, BY TYPE, 2020–2024 (USD MILLION) 180
TABLE 229 SOUTH AMERICA: EMOLLIENTS MARKET, BY TYPE, 2025–2030 (USD MILLION) 180
TABLE 230 SOUTH AMERICA: EMOLLIENTS MARKET, BY TYPE, 2020–2024 (KILOTON) 181
TABLE 231 SOUTH AMERICA: EMOLLIENTS MARKET, TYPE, 2025–2030 (KILOTON) 181
TABLE 232 SOUTH AMERICA: EMOLLIENTS MARKET, BY FORM, 2020–2024 (USD MILLION) 181
TABLE 233 SOUTH AMERICA: EMOLLIENTS MARKET, BY FORM, 2025–2030 (USD MILLION) 181
TABLE 234 SOUTH AMERICA: EMOLLIENTS MARKET, BY FORM, 2020–2024 (KILOTON) 182
TABLE 235 SOUTH AMERICA: EMOLLIENTS MARKET, BY FORM, 2025–2030 (KILOTON) 182
TABLE 236 SOUTH AMERICA: EMOLLIENTS MARKET, BY APPLICATION,
2020–2024 (USD MILLION) 182
TABLE 237 SOUTH AMERICA: EMOLLIENTS MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 183
TABLE 238 SOUTH AMERICA: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 183
TABLE 239 SOUTH AMERICA: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 183
TABLE 240 SOUTH AMERICA: EMOLLIENTS MARKET, BY COUNTRY,
2020–2024 (USD MILLION) 184
TABLE 241 SOUTH AMERICA: EMOLLIENTS MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 184
TABLE 242 SOUTH AMERICA: EMOLLIENTS MARKET, BY COUNTRY, 2020–2024 (KILOTON) 184
TABLE 243 SOUTH AMERICA: EMOLLIENTS MARKET, BY COUNTRY, 2025–2030 (KILOTON) 184
TABLE 244 BRAZIL: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (USD MILLION) 185
TABLE 245 BRAZIL: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 185
TABLE 246 BRAZIL: EMOLLIENTS MARKET, BY APPLICATION, 2020–2024 (KILOTON) 186
TABLE 247 BRAZIL: EMOLLIENTS MARKET, BY APPLICATION, 2025–2030 (KILOTON) 186
TABLE 248 STRATEGIES ADOPTED BY KEY EMOLLIENT MANUFACTURERS,
JANUARY 2020–MAY 2025 187
TABLE 249 EMOLLIENTS MARKET: DEGREE OF COMPETITION 189
TABLE 250 EMOLLIENTS MARKET: REGION FOOTPRINT 195
TABLE 251 EMOLLIENTS MARKET: FORM FOOTPRINT 196
TABLE 252 EMOLLIENTS MARKET: TYPE FOOTPRINT 197
TABLE 253 EMOLLIENTS MARKET: APPLICATION FOOTPRINT 198
TABLE 254 EMOLLIENTS MARKET: KEY STARTUPS/SMES 200
TABLE 255 EMOLLIENTS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 201
TABLE 256 EMOLLIENTS MARKET: PRODUCT LAUNCHES, JANUARY 2020–MAY 2025 204
TABLE 257 EMOLLIENTS MARKET: DEALS, JANUARY 2020–MAY 2025 206
TABLE 258 EMOLLIENTS MARKET: EXPANSIONS, JANUARY 2020–MAY 2025 208
TABLE 259 EMOLLIENT MARKET: OTHER DEVELOPMENTS, JANUARY 2020–MAY 2025 209
TABLE 260 BASF SE: COMPANY OVERVIEW 211
TABLE 261 BASF SE: PRODUCTS OFFERED 212
TABLE 262 BASF SE: PRODUCT LAUNCHES 213
TABLE 263 BASF SE: DEALS 214
TABLE 264 BASF SE: EXPANSIONS 214
TABLE 265 BASF SE: OTHER DEVELOPMENTS 214
TABLE 266 CRODA INTERNATIONAL PLC: COMPANY OVERVIEW 216
TABLE 267 CRODA INTERNATIONAL PLC: PRODUCTS OFFERED 217
TABLE 268 CRODA INTERNATIONAL PLC: PRODUCT LAUNCHES 218
TABLE 269 CRODA INTERNATIONAL PLC: DEALS 218
TABLE 270 CRODA INTERNATIONAL PLC: EXPANSIONS 219
TABLE 271 CRODA INTERNATIONAL PLC: OTHER DEVELOPMENTS 219
TABLE 272 EVONIK INDUSTRIES AG: COMPANY OVERVIEW 221
TABLE 273 EVONIK INDUSTRIES AG: PRODUCTS OFFERED 222
TABLE 274 EVONIK INDUSTRIES AG: PRODUCT LAUNCHES 223
TABLE 275 EVONIK INDUSTRIES AG: DEALS 224
TABLE 276 EVONIK INDUSTRIES AG: EXPANSIONS 224
TABLE 277 EVONIK INDUSTRIES AG: OTHER DEVELOPMENTS 224
TABLE 278 CLARIANT AG: COMPANY OVERVIEW 226
TABLE 279 CLARIANT AG: PRODUCTS OFFERED 227
TABLE 280 CLARIANT AG: PRODUCT LAUNCHES 228
TABLE 281 CLARIANT AG: DEALS 229
TABLE 282 CLARIANT AG: EXPANSIONS 229
TABLE 283 CLARIANT AG: OTHER DEVELOPMENTS 229
TABLE 284 THE LUBRIZOL CORPORATION: COMPANY OVERVIEW 231
TABLE 285 THE LUBRIZOL CORPORATION: PRODUCTS OFFERED 231
TABLE 286 THE LUBRIZOL CORPORATION: PRODUCT LAUNCHES 232
TABLE 287 THE LUBRIZOL CORPORATION: DEALS 232
TABLE 288 THE LUBRIZOL CORPORATION: EXPANSIONS 233
TABLE 289 THE LUBRIZOL CORPORATION: OTHER DEVELOPMENTS 233
TABLE 290 EASTMAN CHEMICAL COMPANY: COMPANY OVERVIEW 235
TABLE 291 EASTMAN CHEMICAL COMPANY: PRODUCTS OFFERED 236
TABLE 292 EASTMAN CHEMICAL COMPANY: PRODUCT LAUNCHES 237
TABLE 293 EASTMAN CHEMICAL COMPANY: DEALS 237
TABLE 294 EASTMAN CHEMICAL COMPANY: EXPANSIONS 238
TABLE 295 EASTMAN CHEMICAL COMPANY: OTHER DEVELOPMENTS 238
TABLE 296 ASHLAND INC.: COMPANY OVERVIEW 239
TABLE 297 ASHLAND INC.: PRODUCTS OFFERED 240
TABLE 298 ASHLAND INC.: PRODUCT LAUNCHES 241
TABLE 299 ASHLAND INC.: DEALS 242
TABLE 300 ASHLAND INC.: EXPANSIONS 242
TABLE 301 INNOSPEC INC.: COMPANY OVERVIEW 243
TABLE 302 INNOSPEC INC.: PRODUCTS OFFERED 244
TABLE 303 INNOSPEC INC.: PRODUCT LAUNCHES 245
TABLE 304 INNOSPEC INC.: EXPANSIONS 245
TABLE 305 LONZA GROUP LTD.: COMPANY OVERVIEW 246
TABLE 306 LONZA GROUP: PRODUCTS OFFERED 247
TABLE 307 STEPAN COMPANY: COMPANY OVERVIEW 249
TABLE 308 STEPAN COMPANY: PRODUCTS OFFERED 250
TABLE 309 KLK OLEO: COMPANY OVERVIEW 252
TABLE 310 SYENSQO SA/NV: COMPANY OVERVIEW 253
TABLE 311 GATTEFOSSÉ: COMPANY OVERVIEW 253
TABLE 312 SASOL LIMITED: COMPANY OVERVIEW 254
TABLE 313 DOW INC.: COMPANY OVERVIEW 254
TABLE 314 COVESTRO AG: COMPANY OVERVIEW 255
TABLE 315 VANTAGE SPECIALTY CHEMICALS: COMPANY OVERVIEW 255
TABLE 316 BERG+SCHMIDT GMBH & CO. KG: COMPANY OVERVIEW 256
TABLE 317 IOI OLEO GMBH: COMPANY OVERVIEW 256
TABLE 318 CARGILL, INC.: COMPANY OVERVIEW 257
TABLE 319 NOURYON: COMPANY OVERVIEW 257
TABLE 320 NIKKO CHEMICALS CO., LTD.: COMPANY OVERVIEW 258
TABLE 321 HALLSTAR: COMPANY OVERVIEW 258
TABLE 322 COLONIAL CHEMICAL, INC.: COMPANY OVERVIEW 259
TABLE 323 ELEMENTIS PLC: COMPANY OVERVIEW 259
TABLE 324 EUROPE: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY,
2020–2024 (USD MILLION) 261
TABLE 325 EUROPE: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 262
TABLE 326 EUROPE: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY,
2020–2024 (KILOTON) 262
TABLE 327 EUROPE: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY,
2025–2030 (KILOTON) 262
TABLE 328 NORTH AMERICA: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY,
2020–2024 (USD MILLION) 263
TABLE 329 NORTH AMERICA: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 263
TABLE 330 NORTH AMERICA: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY,
2020–2024 (KILOTON) 263
TABLE 331 NORTH AMERICA: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY,
2025–2030 (KILOTON) 263
TABLE 332 ASIA PACIFIC: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY,
2020–2024 (USD MILLION) 264
TABLE 333 ASIA PACIFIC: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 264
TABLE 334 ASIA PACIFIC: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY,
2020–2024 (KILOTON) 264
TABLE 335 ASIA PACIFIC: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY,
2025–2030 (KILOTON) 265
TABLE 336 MIDDLE EAST & AFRICA: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY, 2020–2024 (USD MILLION) 265
TABLE 337 MIDDLE EAST & AFRICA: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 265
TABLE 338 MIDDLE EAST & AFRICA: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY, 2020–2024 (KILOTON) 266
TABLE 339 MIDDLE EAST & AFRICA: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY, 2025–2030 (KILOTON) 266
TABLE 340 SOUTH AMERICA: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY,
2020–2024 (USD MILLION) 266
TABLE 341 SOUTH AMERICA: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 267
TABLE 342 SOUTH AMERICA: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY,
2020–2024 (KILOTON) 267
TABLE 343 SOUTH AMERICA: PERSONAL CARE INGREDIENTS MARKET, BY COUNTRY,
2025–2030 (KILOTON) 267
LIST OF FIGURES
FIGURE 1 EMOLLIENTS MARKET SEGMENTATION AND REGIONAL SCOPE 26
FIGURE 2 EMOLLIENTS MARKET: RESEARCH DESIGN 32
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 1 (SUPPLY SIDE): COLLECTIVE MARKET SHARE OF KEY PLAYERS 35
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 2 – BOTTOM-UP (SUPPLY SIDE): COLLECTIVE REVENUE OF ALL PRODUCTS 36
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 3 –
BOTTOM-UP (DEMAND SIDE) 37
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 4 – TOP-DOWN 37
FIGURE 7 EMOLLIENTS MARKET: DATA TRIANGULATION 39
FIGURE 8 MARKET CAGR PROJECTIONS FROM SUPPLY SIDE 40
FIGURE 9 MARKET GROWTH PROJECTIONS FROM DEMAND-SIDE DRIVERS AND OPPORTUNITIES 41
FIGURE 10 ESTERS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2024 43
FIGURE 11 LIQUID FORM TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 44
FIGURE 12 SKIN CARE SEGMENT TO DOMINATE EMOLLIENTS MARKET IN 2025 44
FIGURE 13 EUROPE ACCOUNTED FOR LARGEST MARKET SHARE IN 2024 45
FIGURE 14 RISING USE OF MULTIFUNCTIONAL INGREDIENTS TO CREATE LUCRATIVE OPPORTUNITIES FOR MARKET PLAYERS 46
FIGURE 15 EUROPE TO DOMINATE EMOLLIENTS MARKET DURING FORECAST PERIOD 46
FIGURE 16 SKIN CARE SEGMENT ACCOUNTED FOR LARGEST SHARE OF EUROPEAN EMOLLIENTS MARKET IN 2024 47
FIGURE 17 ESTERS SEGMENT DOMINATED EMOLLIENTS MARKET ACROSS
ALL REGIONS IN 2024 47
FIGURE 18 INDIA TO BE FASTEST-GROWING EMOLLIENTS MARKET DURING FORECAST PERIOD 48
FIGURE 19 EMOLLIENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 50
FIGURE 20 EMOLLIENTS MARKET: PORTER’S FIVE FORCES ANALYSIS 54
FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 56
FIGURE 22 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 57
FIGURE 23 EMOLLIENTS MARKET: SUPPLY CHAIN ANALYSIS 59
FIGURE 24 AVERAGE SELLING PRICE OF EMOLLIENTS OFFERED BY KEY PLAYERS FOR MAJOR APPLICATIONS, 2024 61
FIGURE 25 AVERAGE SELLING PRICE TREND OF EMOLLIENTS, BY REGION,
2022–2030 (USD/KG) 62
FIGURE 26 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 63
FIGURE 27 EMOLLIENT MARKET: ECOSYSTEM ANALYSIS 64
FIGURE 28 IMPORT DATA FOR EMOLLIENTS, BY KEY COUNTRY, 2019–2024 (USD MILLION) 68
FIGURE 29 EXPORT DATA FOR EMOLLIENTS, BY KEY COUNTRY, 2019–2024 (USD MILLION) 69
FIGURE 30 PATENTS REGISTERED FOR EMOLLIENTS, 2014–2024 76
FIGURE 31 MAJOR PATENTS RELATED TO EMOLLIENTS, 2014–2024 77
FIGURE 32 LEGAL STATUS OF PATENTS FILED RELATED TO EMOLLIENTS, 2014–2024 79
FIGURE 33 MAXIMUM PATENTS FILED IN JURISDICTION OF US, 2014–2024 80
FIGURE 34 IMPACT OF AI/GEN AI ON EMOLLIENTS MARKET 85
FIGURE 35 ESTERS SEGMENT TO LEAD EMOLLIENTS MARKET DURING FORECAST PERIOD 88
FIGURE 36 LIQUID FORM SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 106
FIGURE 37 SKIN CARE SEGMENT TO LEAD EMOLLIENTS MARKET DURING FORECAST PERIOD 114
FIGURE 38 EUROPE TO LEAD EMOLLIENTS MARKET DURING FORECAST PERIOD 126
FIGURE 39 ASIA PACIFIC: EMOLLIENTS MARKET SNAPSHOT 128
FIGURE 40 NORTH AMERICA: EMOLLIENTS MARKET SNAPSHOT 141
FIGURE 41 EUROPE: EMOLLIENTS MARKET SNAPSHOT 152
FIGURE 42 EMOLLIENTS MARKET SHARE ANALYSIS OF TOP FIVE PLAYERS, 2024 189
FIGURE 43 EMOLLIENTS MARKET: REVENUE ANALYSIS OF KEY PLAYERS,
2020–2024 (USD MILLION) 191
FIGURE 44 EMOLLIENTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 193
FIGURE 45 EMOLLIENTS MARKET: COMPANY FOOTPRINT 194
FIGURE 46 EMOLLIENTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 200
FIGURE 47 BRAND/PRODUCT COMPARISON 202
FIGURE 48 EMOLLIENTS MARKET: EV/EBITDA OF KEY MANUFACTURERS 203
FIGURE 49 EMOLLIENTS MARKET: ENTERPRISE VALUATION OF KEY PLAYERS 203
FIGURE 50 BASF SE: COMPANY SNAPSHOT 212
FIGURE 51 CRODA INTERNATIONAL PLC: COMPANY SNAPSHOT 217
FIGURE 52 EVONIK INDUSTRIES AG: COMPANY SNAPSHOT 222
FIGURE 53 CLARIANT AG: COMPANY SNAPSHOT 227
FIGURE 54 EASTMAN CHEMICAL COMPANY.: COMPANY SNAPSHOT 236
FIGURE 55 ASHLAND INC.: COMPANY SNAPSHOT 240
FIGURE 56 INNOSPEC INC.: COMPANY SNAPSHOT 244
FIGURE 57 LONZA GROUP LTD.: COMPANY SNAPSHOT 247
FIGURE 58 STEPAN COMPANY: COMPANY SNAPSHOT 250
MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | USD9,150 | USD9,650 | USD11,500 |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 軟組織修復市場 – 2030年までの世界予測 2025-07-02
- エポキシ樹脂市場 – 2030年までの世界予測 2025-07-02
- スマートガスメーター市場 – 2030年までの世界予測 2025-07-02
- サイバーセキュリティ市場 – 2030年までの世界予測 2025-07-02
- パイプ用断熱材市場 – 2030年までの世界予測 2025-07-01